Clinical Trial Update: Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial results for apixaban in the treatment of venous thromboembolism in cancer patients have been posted after study completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Apixaban (Eliquis) (apixaban)

Snippet

Sponsor: Fadoi Foundation, Italy | Conditions: Venous Thromboembolism | Phase 3 | Status: COMPLETED | Results posted: 2025-06-18